Bionano Genomics, Inc. (BNGO) Earnings Call Transcript & Summary
September 29, 2020
Earnings Call Speaker Segments
Operator
operatorGood day, ladies and gentlemen, and thank you for standing by. Welcome to the Bionano Genomics' Conference Call. At this time, I would like to turn the conference over to Mr. Erik Holmlin.
Robert Holmlin
executiveThank you, and good morning, everyone. I am Erik Holmlin, President and Chief Executive Officer of Bionano Genomics. And I will serve today as the Chair, Secretary and inspector of election of today's meeting. And so welcome again to the Bionano's Special Meeting of Stockholders. As you know, this meeting was originally convened at 10:00 a.m. Pacific Time on August 31, 2020. At that time, we announced the adjournment of the meeting until today to allow Bionano additional time to solicit proxies for Proposal 1 relating to an amendment to our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of our common stock from 200 million to 400 million shares. At this time, the meeting will now officially come to order. The time is now 10:01 a.m. on September 29, 2020, and the polls are open for voting on Proposal 1 as set forth in the proxy statement for the special meeting. [Voting]
Robert Holmlin
executiveThe time is now 10:02 a.m., and the polls are now closed for voting on Proposal 1. In my capacity as the inspector of election, I hereby report as follows: Proposal 1, to approve an amendment to Bionano's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 200 million to 400 million shares is carried. We expect to report our preliminary voting results, or if available to us on a timely basis, our final voting results on an amendment to our current report on Form 8-K to be filed with the SEC within 4 business days from now. If not reported earlier, we expect to report our final voting results in amendment to our Form 8-K within 4 business days after the final results are known to us. This concludes our special meeting of stockholders. Thank you for your attendance today and for your continued support of Bionano.
For developers and AI pipelines
Programmatic access to Bionano Genomics, Inc. earnings transcripts and 32,000+ others is available through the
EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.